WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, December 5, 2007, 27(49):13371-13375; doi:10.1523/JNEUROSCI.2398-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horvath, M. Cs.
Right arrow Articles by Keller, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horvath, M. Cs.
Right arrow Articles by Keller, E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*Genetics Home Reference
Medline Plus Health Information
*Heroin
*Seniors' Health

 Previous Article  |  Next Article 

Brief Communications
Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age

Monika Cs. Horvath,1 Gabor G. Kovacs,2 Viktor Kovari,2 Katalin Majtenyi,2 Yasmin L. Hurd,3 * and Eva Keller1 *

1Department of Forensic Medicine, Semmelweis University, H-1085, Budapest, Hungary, 2National Institute of Psychiatry and Neurology, H-1021, Budapest, Hungary, and 3Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029

Correspondence should be addressed to Yasmin L. Hurd, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1215, New York, NY 10029. Email: Yasmin.Hurd{at}mssm.edu

Dysfunction of mesocorticolimbic dopaminergic neurons is considered a common feature of all drugs of abuse, yet few investigations have evaluated the dopamine (DA) system in nonstimulant human abusers. We examined mRNA expression levels of DA transporter (DAT), tyrosine hydroxylase (TH), dopamine D2 receptor, {alpha}-synuclein, and nuclear receptor-related 1 (Nurr1) in discrete mesocorticolimbic and nigrostriatal subpopulations of heroin users and control subjects. The chronic use of heroin was significantly associated with decreased DAT mRNA expression localized to the paranigral nucleus (PN) and the mesolimbic division of the ventral tegmental area (VTA) with no alterations in nigrostriatal populations. Consistently, the density of DAT immunoreactivity was significantly reduced in the nucleus accumbens but not in dorsal striatum, mesolimbic and nigrostriatal efferent targets, respectively. Significant alteration of the mRNA expression of Nurr1, a transcription factor that regulates DAT expression, was also confined to the PN. Moreover, the results revealed an exaggerated reduction of Nurr1 expression with age in heroin users (r = –0.8268, p < 0.001 vs controls, r = –0.6204, p = 0.0746). TH and {alpha}-synuclein mRNA levels were, in contrast, elevated in the VTA PN in heroin users with no change of the D2 receptor. Evaluating midbrain µ- and {kappa}-opioid receptors, relevant for the action of heroin and regulation of DA neurons, revealed dysregulation of G-protein coupling selective to the VTA PN. Altogether the current findings provide direct neurobiological evidence that midbrain reward circuits have the most prominent DA and opioid impairments in human heroin abusers and that abnormal Nurr1 transcription with opiate use may exacerbate limbic dysfunction with age.

Key words: dopamine transporter; {alpha}-synuclein; human; µ-opioid receptor; substantia nigra; periaqueductal gray


Received May 25, 2007; revised Sept. 20, 2007; accepted Oct. 9, 2007.

Correspondence should be addressed to Yasmin L. Hurd, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1215, New York, NY 10029. Email: Yasmin.Hurd{at}mssm.edu






-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-